Cargando…
Phase 2 Trial of Monoamine Oxidase Inhibitor Phenelzine in Biochemical Recurrent Prostate Cancer
PURPOSE: Monoamine oxidase A (MAOA) influences prostate cancer growth and metastasis in pre-clinical models. We examined effects of phenelzine (a monoamine oxidase inhibitor) in patients with biochemical recurrent castrate-sensitive prostate cancer. MATERIALS AND METHODS: An open-label single arm cl...
Autores principales: | Gross, Mitchell E., Agus, David B., Dorff, Tanya B., Pinski, Jacek K., Quinn, David I., Castellanos, Olga, Gilmore, Patrick, Shih, Jean C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483294/ https://www.ncbi.nlm.nih.gov/pubmed/32123315 http://dx.doi.org/10.1038/s41391-020-0211-9 |
Ejemplares similares
-
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015) -
A Phase II Trial of a Combination Herbal Supplement for Men with Biochemically Recurrent Prostate Cancer
por: Dorff, Tanya B., et al.
Publicado: (2014) -
Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine
por: Matveychuk, Dmitriy, et al.
Publicado: (2021) -
Immune Response to Sipuleucel-T in Prostate Cancer
por: Thara, Eddie, et al.
Publicado: (2012) -
Monoamine Oxidases—New Vistas. Advances in Biochemical Psychopharmacology. Volume 5
por: Biber, Margaret
Publicado: (1974)